| Stage | DVA | % of rev | VMD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.6B | 100.00% | $81M | 100.00% | DVA ×44.35 |
| Gross profit | $1.1B | 31.50% | $46M | 57.26% | VMD +25.8pp |
| Operating income | $499M | 13.95% | $7M | 8.63% | DVA +5.3pp |
| Pre-tax income | $359M | 10.02% | $7M | 8.41% | DVA +1.6pp |
| Net income | $269M | 7.53% | $5M | 5.87% | DVA +1.7pp |
| Stage | DVA | VMD | Gap · A − B |
|---|---|---|---|
| Revenue | $3.6B100.00% | $81M100.00% | DVA ×44.35 |
| Gross profit | 31.50%$1.1B | 57.26%$46M | VMD +25.8pp |
| Operating income | 13.95%$499M | 8.63%$7M | DVA +5.3pp |
| Pre-tax income | 10.02%$359M | 8.41%$7M | DVA +1.6pp |
| Net income |
| 7.53%$269M |
| 5.87%$5M |
| DVA +1.7pp |
No shared counterparties.